Exosome Diagnostics and Therapeutics Market to Reach $2.9 Billion Globally by 2030 at a CAGR of 29.4%: Allied Market Research

Rising use of multifunctional property of exosome therapy for chronic heart failure, Alzheimer’s disease, Parkinson’s disease and cancer is driving the growth of the global market diagnostic and therapeutic market for exosomes.

PORTLAND, Oregon., May 30, 2022 /PRNewswire/ –Allied Market Research released a report titled “Exosome Diagnostics and Therapeutics Market By Application (Diagnostic, Therapeutic), By Product (Instrument, Reagent, and Software) By End User (Cancer Institute, Hospital, Diagnostic Center, Others): Global Opportunities Analysis and Industry Forecast, 2020-2030. According to the report, the global exosome diagnostics and therapeutics industry was estimated to be $224.34 million in 2020, and should reach $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030.

Download a sample PDF at: https://www.alliedmarketresearch.com/request-sample/1723

Determinants of Growth-

Rise in the use of multifunctional property of exosome therapy for chronic heart failure, Alzheimer’s disease, Parkinson’s disease and cancer is driving the growth of the global exosome diagnostics and therapy market the exosomes. On the other hand, increasing demand for drug therapies and booming R&D activities in pharmaceutical and biopharmaceutical fields further complement the market growth. Additionally, increasing potential application of exosomes in cancer diagnosis and development of translational precision drugs are expected to create lucrative opportunities in the industry.

Covid-19 scenario-

  • The rapid spread of Covid-19 has increased the need for molecular diagnostics, thereby positively impacting the global exosome diagnostics and therapeutics market.
  • This trend is expected to continue until the pandemic is completely over.

The diagnostics segment to dominate by 2030-

Based on application, the diagnostics segment accounted for more than two-thirds of the global exosome diagnostics and therapeutics market share in 2020, and is expected to rule the roost by 2030. The same segment would also cite fastest CAGR of 29.5% throughout the forecast period, due to rising incidence of chronic diseases and increasing demand for early diagnosis.

Specific requirement on COVID-19? Ask our industry expert: https://www.alliedmarketresearch.com/purchase-enquiry/1723

The instruments segment to keep the lion’s share

Based on product, the instruments segment held nearly three-fifths of the global exosome diagnostic and therapeutic market revenue in 2020 and is expected to lead the way by 2030. This is driven by the increase in the need for molecular diagnostics and to the increase of R&D activities for the purpose of diagnosis. The software segment, on the other hand, would manifest the Fastest CAGR of 30.2% from 2020 to 2030. This is attributed to the progress of R&D activities in the healthcare sector and the increase in the number of key manufacturers across the world.

North America collected most of it in 2020-

Based on the region, North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostics and therapeutics market, owing to the increase in product launches for exosome therapeutics, strong presence of key players and the development of R&D activities in the pharmaceutical and biopharmaceutical sector throughout the province. Asia Pacifichowever, would grow at the fastest CAGR of 30.3% by 2030. Rising prevalence of chronic and infectious disorders, growing healthcare expenditures and rising demand for molecular diagnostics are driving the growth of the market in the region.

Key Industry Players-

  • Exosome Diagnostics Inc.
  • NanoSomix Inc.
  • Thermo Fisher Scientific Inc.
  • Malvern Instruments Ltd.
  • System Biosciences Inc.
  • NX Pharmagene
  • Aethlon Medical, Inc.
  • Sistemic Inc.

Avenue Basic Plan | Access to the library | 1 year subscription |

Sign up for the Avenue subscription to access over 12,000 company profiles and over 2,000 niche market research reports on $699 per month, per seat. For one year, the customer must purchase a minimum 2-seat plan.

14-day free trial request: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published some syndicated market studies in the same field that you may be interested in. Below is the title of the report for your referenceconsidering the impact of Covid-19 on this market which will help you to assess the aftereffects of the pandemic on the short and long term growth trends of this market.”

Reports on trends in the healthcare industry (book now with 10% discount):

Remote Patient Monitoring Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Pharmaceutical Packaging Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Pulse Oximeter Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Ophthalmic Lasers Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Molecular Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Forensic Technology Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Medical Device Coatings Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Women’s Health Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

AI in Healthcare Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

Gene Therapy Market – Global Opportunity Analysis and Industry Forecast, 2020-2030

About Us

Allied Market Research (AMR) is a full-service market research and business advisory division of Allied Analytics LLP based in Portland, OR. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions“. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

Pawan KumarCEO of Allied Market Research, directs the organization towards the provision of high quality data and information. We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
UNITED STATES/Canada (Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
hong kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
The Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

SOURCE Allied Market Research


Source link

Sandy A. Greer